Silexion Therapeutics 

$0.3518
30
+$0.00+0.06% Friday 20:00
+$0.00+0.11%Friday 23:44After hours

Statistics

Day High
0.3516
Day Low
0.3516
52W High
77.7
52W Low
0.35
Volume
198
Avg. Volume
-
Mkt Cap
1.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-21.2
-14.39
-7.58
-0.77
Expected EPS
-9.1
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2024
2025
0Revenue
-11.91MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SLXN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for cancers driven by mutations in the mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS). Its proprietary technology is designed to prompt tumor cells to degrade the messenger RNA (mRNA) that bridges the oncogene and the cellular protein synthesis machinery, utilizing small interfering RNA (siRNA) constructs that are chemically modified to enhance stability and cellular uptake while maintaining biological activity that interferes with the mRNA function. Its product candidate, SIL204, is a second-generation siRNA engineered to suppress the production of mutated KRAS proteins.
Show more...
CEO
Ilan Hadar
Employees
13
Country
Cayman Islands
ISIN
KYG1281K1489

Listings

0 Comments

Share your thoughts

FAQ

What is Silexion Therapeutics stock price today?
The current price of SLXN is $0.35 USD — it has increased by +0.06% in the past 24 hours. Watch Silexion Therapeutics stock price performance more closely on the chart.
What is Silexion Therapeutics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Silexion Therapeutics stocks are traded under the ticker SLXN.
Is Silexion Therapeutics stock price growing?
SLXN stock has fallen by -3.09% compared to the previous week, the month change is a -80.46% fall, over the last year Silexion Therapeutics has showed a -99.51% decrease.
What is Silexion Therapeutics market cap?
Today Silexion Therapeutics has the market capitalization of 1.96M
When is the next Silexion Therapeutics earnings date?
Silexion Therapeutics is going to release the next earnings report on November 18, 2026.
What were Silexion Therapeutics earnings last quarter?
SLXN earnings for the last quarter are -5.17 USD per share, whereas the estimation was -21.2 USD resulting in a +75.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Silexion Therapeutics revenue for the last year?
Silexion Therapeutics revenue for the last year amounts to 0 USD.
What is Silexion Therapeutics net income for the last year?
SLXN net income for the last year is -11.91M USD.
How many employees does Silexion Therapeutics have?
As of September 05, 2026, the company has 13 employees.
In which sector is Silexion Therapeutics located?
Silexion Therapeutics operates in the Health & Wellness sector.
When did Silexion Therapeutics complete a stock split?
The last stock split for Silexion Therapeutics was on May 29, 2026 with a ratio of 1:10.
Where is Silexion Therapeutics headquartered?
Silexion Therapeutics is headquartered in RAMAT GAN, Cayman Islands.